Novel polypeptide of protein p140 and DNAs encoding it
AssigneeOno Pharmaceutical Co., Ltd.
InventorsHisao Tajima, Koichiro Kitagawa, Hiroyuki Ohno
Life of this patent
Estimating the term…
Loading patent…
AssigneeOno Pharmaceutical Co., Ltd.
InventorsHisao Tajima, Koichiro Kitagawa, Hiroyuki Ohno
Estimating the term…
The present invention is related to a novel protein p140 polypeptide which is a key protein involved in the signal transmission system of insulin; method for preparation of it; DNA encoding the said polypeptide; vector derived the said DNA; host cells transformed the said vector; antibody of the said polypeptide; pharmaceutical composition containing the said peptide or antibody; method for the prevention and/or treatment of diabetes, which is characterized by tyrosine phosphorylation of the said protein p140; agent for the prevention and/or treatment for the currently said the prevention and/or treatment method; agent for the prevention and/or treatment of diabetes, which is characterized by containing a compound which can tyrosine phosphorylation of protein p140, as active ingredient and the screening methods of the said prevention and/or treatment agent. Tyrosine phosphorylation of protein p140 is an essential step in the induction of hypoglycemia by glucose uptake. Method and agent of prevention and/or treatment based on tyrosine phosphorylation of protein p140 in the present invention is not only improve the diabetes-derived hyperglycemic conditions but are also useful for the treatment and/or prevention of diabetes, especially non-insulin dependent diabetes mellitus (NIDDM).
A polypeptide of protein p140 having the amino acid sequence shown in SEQ ID No. 1 in substantially purified form, a homologue thereof or a fragment of the sequence or homologue of a fragment.
A method for the prevention and/or treatment of diabetes, which is characterized of tyrosine phosphorylation of protein p140.
An agent for the prevention and/or treatment of diabetes, which characterized of tyrosine phosphorylation of protein p140.
An agent for the prevention and/or treatment of diabetes characterized by containing a compound which can tyrosine phosphorylation of protein p140, as active ingredient.
A method for the screening of the agent for the prevention and/or treatment of diabetes, which is characterized by using protein p140.
Dependencies are inferred from the claim text.